Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer
Stock Information for Q32 Bio Inc Com
Loading
Please wait while we load your information from QuoteMedia.